Stay updated on Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check18 days agoChange DetectedA sitewide NIH notice was added, directing visitors to transition updates and explaining that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.2%

- Check25 days agoChange DetectedThe website footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check32 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page footer now shows revision v3.7.0 replacing the previous v3.6.6, representing an update to the ClinicalTrials.gov study history page.SummaryDifference0.0%

- Check75 days agoChange DetectedFooter revision label updated from v3.6.5 to v3.6.6, indicating a new site release version. This change affects only metadata display and does not modify the study record content or history entries.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.